Abstract
Synthetic graft expanders have recently been developed for use in impaction grafting revision hip arthroplasty, but their true role has yet to be determined.
We performed a series of experiments to investigate the properties of one such porous hydroxyapatite material (IG-Pore, ApaTech Ltd). IG-Pore was mixed with fresh-frozen human allograft chips and impacted into composite femoral models with a similar biomechanical profile to human bone (Sawbones Europe). Exeter hip prostheses (Stryker Howmedica Ltd) were implanted with cement and each model was axially loaded for 18000 cycles at physiological levels using an Instron servohydraulic materials testing machine. Four test groups with 0%, 50%, 70% and 90% IG-Pore were used, and there were eight femora in each group.
Pre- and post-loading radiostereometric analysis was performed to characterise migration of the prosthesis. Total subsidence was measured and was separated into that occurring at the prosthesis-cement and cement-femur interfaces. Cyclical compression and expansion of the graft-containing models was measured using the Instron.
Median values (interquartile range) for total subsidence were 0.43 mm (0.28 to 0.55) for the pure allograft group, 0.31 mm (0.20 to 0.55) for the 50% IG-Pore group, 0.23 mm (0.07 to 0.34) for the 70% allograft group and 0.13 mm (0.06 to 0.18) for the 90% IG-Pore group. These differences were statistically significant (p=0.034, Kruskal-Wallis). Subsidence at the prosthesis-cement interface was also lower for IG-Pore containing models (p=0.019, Kruskal-Wallis), although there was no significant difference at the cement-femur interface. Specimens with a higher proportion of IG-Pore showed smaller cyclical movements on loading (p=0.005, ANOVA).
Higher proportions of IG-Pore do appear to reduce subsidence in a mechanical model of impaction grafting. A randomised clinical trial using RSA to compare a 50% IG-Pore/allograft mix with pure allograft is in progress to investigate the use of this material as a bone graft expander in the clinical setting.
Editoral Secretary Mr Peter Howard. Correspondence should be addressed to BHS at the Royal College of Surgeons, 35 - 43 Lincoln’s Inn Fields, London WC2A 3PN.
